DesiCorp, Inc.

Biotech Louisville, KY

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
Louisville, KY
Street
201 E. Jefferson Street
Zip
40202

Offering

Total offering
$5M
Amount sold
$840k
First sale
Mar 20, 2026
Min investment
$0
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
8

How this filing compares

Ranked #16 of 47 Biotech filings in April 2026 by offering amount.

Median Biotech filing in April 2026: $3M. This offering is 1.7× the median.

Other Kentucky filings this week: KIVQORO GROUP US Ltd., WINDSTONE INVESTMENT, LLC, eGateway Capital II-13, LLC, Specialty Insurance Marketing Services, LLC

Leadership

Brett Janis — Executive Officer (also: Director)

Jonathan Kopecheck — Executive Officer (also: Director)

Michael Menze — Executive Officer (also: Director)

Robert Saunders — Director

Filing details

DesiCorp, Inc. filed a Form D with the SEC on April 1, 2026.

Other newest Biotech companies

Other newest companies in Kentucky